Atea Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 31.57

AVIR -  USA Stock  

USD 31.57  2.57  8.86%

Atea Pharmaceuticals' future price is the expected price of Atea Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Atea Pharmaceuticals performance during a given time horizon utilizing its historical volatility. As of 09/28/2021, Price to Book Value is likely to drop to 5.64. In addition to that, Price to Earnings Ratio is likely to drop to -79.55.

Search Price Probability 

 
Refresh
Atea Pharmaceuticals' implied volatility is one of the determining factors in the pricing options written on Atea Pharmaceuticals. Implied volatility approximates the future value of Atea Pharmaceuticals based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Atea Pharmaceuticals over a specific time period. For example, 2021-10-15 CALL at $30.0 is a CALL option contract on Atea Pharmaceuticals' common stock with a strick price of 30.0 expiring on 2021-10-15. The contract was last traded on 2021-09-24 at 14:36:48 for $4.3 and, as of today, has 18 days remaining before the expiration. The option is currently trading at a bid price of $4.0, and an ask price of $4.5. The implied volatility as of the 28th of September is 105.0237. View All Atea Pharmaceuticals options

Closest to current price Atea Pharmaceuticals long CALL Option Payoff at Expiration

Please continue to Trending Equities.Please specify Atea Pharmaceuticals time horizon, a valid symbol (red box) and a target price (blue box) you would like Atea Pharmaceuticals odds to be computed.
Apply Odds

Atea Pharmaceuticals Target Price Odds to finish over 31.57

The tendency of Atea Pharmaceuticals Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for foresting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 31.57 90 days 31.57  about 6.12
Based on a normal probability distribution, the odds of Atea Pharmaceuticals to move above the current price in 90 days from now is about 6.12 (This Atea Pharmaceuticals probability density function shows the probability of Atea Pharmaceuticals Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.12 . This suggests Atea Pharmaceuticals market returns are sensible to returns on the market. As the market goes up or down, Atea Pharmaceuticals is expected to follow. Additionally The company has an alpha of 0.4746, implying that it can generate a 0.47 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Atea Pharmaceuticals Price Density 
      Price 

Predictive Modules for Atea Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Atea Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Atea Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Atea Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
27.1631.7836.40
Details
Intrinsic
Valuation
LowReal ValueHigh
28.4140.2144.83
Details
Naive
Forecast
LowNext ValueHigh
28.0132.6337.25
Details
5 Analysts
Consensus
LowTarget PriceHigh
37.0051.0060.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Atea Pharmaceuticals. Your research has to be compared to or analyzed against Atea Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Atea Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Atea Pharmaceuticals.

Atea Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Atea Pharmaceuticals is not an exception. The market had few large corrections towards the Atea Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Atea Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Atea Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over DOW
0.47
β
Beta against DOW1.12
σ
Overall volatility
3.10
Ir
Information ratio 0.1

Atea Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Atea Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Atea Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Atea Pharmaceuticals is not yet fully synchronised with the market data
Atea Pharmaceuticals appears to be risky and price may revert if volatility continues
Atea Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 48.63 M. Net Loss for the year was (10.95 M) with profit before overhead, payroll, taxes, and interest of 33.65 M.
Atea Pharmaceuticals has a poor financial position based on the latest SEC disclosures
About 58.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on Thursday - Yahoo Finance

Atea Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Atea Pharmaceuticals Stock often depends not only on the future outlook of the current and potential Atea Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atea Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out5.14%
Short Percent Of Float5.66%
Float Shares49.08M
Shares Short Prior Month2.24M
Average Daily Volume Last 10 Day2.14M
Average Daily Volume In Three Month1.41M
Date Short Interest15th of April 2021

Atea Pharmaceuticals Technical Analysis

Atea Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Atea Pharmaceuticals Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Atea Pharmaceuticals. In general, you should focus on analyzing Atea Pharmaceuticals Stock price patterns and their correlations with different microeconomic environments and drivers.

Atea Pharmaceuticals Predictive Forecast Models

Atea Pharmaceuticals time-series forecasting models is one of many Atea Pharmaceuticals' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Atea Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Atea Pharmaceuticals

Checking the ongoing alerts about Atea Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Atea Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Atea Pharmaceuticals Alerts

Atea Pharmaceuticals Alerts and Suggestions

Atea Pharmaceuticals is not yet fully synchronised with the market data
Atea Pharmaceuticals appears to be risky and price may revert if volatility continues
Atea Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 48.63 M. Net Loss for the year was (10.95 M) with profit before overhead, payroll, taxes, and interest of 33.65 M.
Atea Pharmaceuticals has a poor financial position based on the latest SEC disclosures
About 58.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on Thursday - Yahoo Finance
Please continue to Trending Equities. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
The market value of Atea Pharmaceuticals is measured differently than its book value, which is the value of Atea Pharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Atea Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Atea Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea Pharmaceuticals' market value can be influenced by many factors that don't directly affect Atea Pharmaceuticals underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Atea Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.